Arterial Spin Labelling Initiative in Dementia

The COST Action “Arterial Spin Labelling (ASL) Initiative in Dementia (AID)” is a four year project which was launched in December 2011. The consortium, which is led by Prof. Xavier Golay (UK), is made up of field experts from 12 different European countries.

This grant focuses on the specific health-care problem of dementia. With care-costs approaching 1% of the global Gross Domestic Product (World Alzheimer Report, 2010), and with an ageing global population, dementia represents a major clinical challenge. For Alzheimer’s disease, which is the most common cause of dementia, revised diagnostic criteria have recently been proposed and they now incorporate biomarkers which are mostly based on imaging.

ASL is still underutilised at present due to the heterogeneity and multiplicity of its implementations. Technological improvement and the standardisation of acquisition and post-processing methods are therefore considered essential to enable ASL to evolve into a general clinical tool. This grant will allow for the harmonisation of resources, the coordination of efforts, and the optimal use of pre-existing facilities in Europe.

To date, no other consortium has been tasked with coordinating the development of any MRI technology, and EIBIR will play a crucial role in the administration of this four-year project.

The principle of such grants is that anyone can join the Action at any point in time. In the spirit of this principle, the Action’s working group would be pleased to welcome any member of the MRI community interested in joining this endeavour.

To find out more, or to express an interest in joining this action, please refer to the Arterial Spin Labelling website, or email us at the EIBIR office.